According to one embodiment, a protective device for use in congestive heart failure treatments, and other treatments, includes a control mechanism, an elongate shaft, and a protective plate. The control mechanism is coupled with a proximal end of the elongate shaft and the protective plate is ...
Ventricular Assist Devices as Alternatives to Biologic Replacement of the Heart Despite significant advances in both medical and surgical therapy for congestive heart failure, the incidence and prevalence of this syndrome continue to r... B Bozkurt,S Murali - 《Cardiology in Review》 被引量: 1发表...
Heart failure (HF) is one of the leading causes of global health impairment. Current drugs are still limited in their effectiveness in the treatment and reversal of HF: for example, drugs for acute HF (AHF) help to reduce congestion and relieve symptoms, but they do little to improve surviv...
Heart failure is a growing epidemic, with more patients living longer and suffering from this disease. There is a growing segment of patients who have persistent symptoms despite pharmacologic therapy. In an era when transplants are rare, the need for devices and interventions that can assist vent...
Left ventricular assist devices (LVADs) are increasingly used as therapeutic options for patients with advanced congestive heart failure (CHF), many of who... N Uriel,Y Naka,PC Colombo,... - 《European Journal of Heart Failure》 被引量: 60发表: 2014年 Left ventricular mobile thrombus associa...
A method of treatment of congestive heart failure comprises the steps of introducing an aortic occlusion catheter through a patient's peripheral artery, the aortic occlusion catheter having an occluding member movable from a collapsed position to an expanded position; positioning the occluding member in...
Beta-adrenergic blocker mortality trials in congestive heart failure This article reviews the early studies that initiated this revolution in heart failure therapy and discusses the major mortality trials that have demonstrated ... JR Teerlink,BM Massie - 《American Journal of Cardiology》 被引量: 79...
Nontransplant surgical options for congestive heart failure Although advanced heart failure has been considered the main indication for heart transplantation, the increasing number of candidates and shortage of orga... AR Kherani,MJ Garrido,FH Cheema,... - 《Current Cardiology Reports》 被引量: 7发...
Among the treatment options for congestive heart failure, ventricular assist devices (VADs) are an emerging new technology, which may serve as a realistic therapeutic option once the complication rate is reduced. Whereas these devices were used in the past almost exclusively as a bridge to transpla...
et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N. Engl. J. Med. 361, 1329–1338 (2009). PubMed Google Scholar Leclercq, C. et al. A randomized comparison of triple-site versus dual-site ventricular stimulation in patients with congestive heart failure....